Breast Cancer Classification Using Deep Convolutional Neural Networks

Breast cancer remains the primary causes of death for women and much effort has been depleted in the form of screening series for prevention. Given the exponential growth in the number of mammograms collected, computer-assisted diagnosis has become a necessity. Histopathological imaging is one of the methods for cancer diagnosis where Pathologists examine tissue cells under different microscopic standards but disagree on the final decision. In this context, the use of automatic image processing techniques resulting from deep learning denotes a promising avenue for assisting in the diagnosis of breast cancer. In this paper, an android software for breast cancer classification using deep learning approach based on a Convolutional Neural Network (CNN) was developed. The software aims to classify the breast tumors to benign or malignant. Experimental results on histopathological images using the BreakHis dataset shows that the DenseNet CNN model achieved high processing performances with 96% of accuracy in the breast cancer classification task when compared with state-of-the-art models

An evaluation of DNA-damage response and cell-cycle pathways for breast cancer classification

Accurate subtyping or classification of breast cancer is important for ensuring proper treatment of patients and also for understanding the molecular mechanisms driving this disease. While there have been several gene signatures proposed in the literature to classify breast tumours, these signatures show very low overlaps, different classification performance, and not much relevance to the underlying biology of these tumours. Here we evaluate DNA-damage response (DDR) and cell cycle pathways, which are critical pathways implicated in a considerable proportion of breast tumours, for their usefulness and ability in breast tumour subtyping. We think that subtyping breast tumours based on these two pathways could lead to vital insights into molecular mechanisms driving these tumours. Here, we performed a systematic evaluation of DDR and cell-cycle pathways for subtyping of breast tumours into the five known intrinsic subtypes. Homologous Recombination (HR) pathway showed the best performance in subtyping breast tumours, indicating that HR genes are strongly involved in all breast tumours. Comparisons of pathway based signatures and two standard gene signatures supported the use of known pathways for breast tumour subtyping. Further, the evaluation of these standard gene signatures showed that breast tumour subtyping, prognosis and survival estimation are all closely related. Finally, we constructed an all-inclusive super-signature by combining (union of) all genes and performing a stringent feature selection, and found it to be reasonably accurate and robust in classification as well as prognostic value. Adopting DDR and cell cycle pathways for breast tumour subtyping achieved robust and accurate breast tumour subtyping, and constructing a super-signature which contains feature selected mix of genes from these molecular pathways as well as clinical aspects is valuable in clinical practice.Comment: 28 pages, 7 figures, 6 table

Efficient breast cancer classification network with dual squeeze and excitation in histopathological images.

Medical image analysis methods for mammograms, ultrasound, and magnetic resonance imaging (MRI) cannot provide the underline features on the cellular level to understand the cancer microenvironment which makes them unsuitable for breast cancer subtype classification study. In this paper, we propose a convolutional neural network (CNN)-based breast cancer classification method for hematoxylin and eosin (H&E) whole slide images (WSIs). The proposed method incorporates fused mobile inverted bottleneck convolutions (FMB-Conv) and mobile inverted bottleneck convolutions (MBConv) with a dual squeeze and excitation (DSE) network to accurately classify breast cancer tissue into binary (benign and malignant) and eight subtypes using histopathology images. For that, a pre-trained EfficientNetV2 network is used as a backbone with a modified DSE block that combines the spatial and channel-wise squeeze and excitation layers to highlight important low-level and high-level abstract features. Our method outperformed ResNet101, InceptionResNetV2, and EfficientNetV2 networks on the publicly available BreakHis dataset for the binary and multi-class breast cancer classification in terms of precision, recall, and F1-score on multiple magnification levels